EX-16.1 2 v317765_ex16-1.htm EXHIBIT 16.1

 

July 9, 2012

Office of the Chief Accountant

Securities and Exchange Commission

100 F Street, NE

Washington, DC 20549

Re: Synthetic Biologics, Inc.

File Reference No. 1-12584

We have read Synthetic Biologics, Inc.’s statements included in Item 4.01 on Form 8-K. We agree with such statements made regarding our firm.

We consent to the filing of this letter as an exhibit to the foregoing report on Form 8-K.

Very truly yours,

Berman & Company, P.A.